Format

Send to:

Choose Destination
See comment in PubMed Commons below
Drug Ther Bull. 2012 Jul;50(7):78-80. doi: 10.1136/dtb.2012.06.0115.

Exenatide for once-weekly administration.

[No authors listed]

Abstract

▾Exenatide is a glucagon-like peptide 1 (GLP-1) agonist used in the management of people with type 2 diabetes. A twice-daily injectable formulation (▾Byetta - Eli Lilly) was licensed in 2006. ▾Bydureon (Eli Lilly) is a prolonged-release injectable formulation that allows once-weekly administration. Here we discuss the place of Bydureon in the management of type 2 diabetes mellitus.

PMID:
22789767
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk